At 09.53 30/11/98 -0800, you wrote:
>At my local health authority we're surprised that we can't find a really
>good set of osteoporosis prevention/treatment guidleines to serve as a
>starting point for our health improvement plan. We'd like a set that covers
>primary prevention (e.g. children's diets), secondary prevention, lifestlye,
>and "rationing" of expensive invesigations and drugs. Can anyone help?
>thanks
I alert you about some of guidelines of our database
Osteoporosis Guidelines of Canadian Medical Association
http://www.cma.ca/cpgs/osteocpg.htm
Bisphosphonates (alendronate and etidronate) in the management of osteoporosis
Best L, Milne R Southampton: Wessex Institute for Health Research and
Development 1998 DEC Report No. 79 [988897]
http://www.epi.bris.ac.uk/rd/publicat/dec/dec79.htm
Bone mineral density testing: does the evidence support its selective use
in well
women? Green C J, Bassett K, Foerster V, Kazanjian A Vancouver: B.C. Office
of Health Technology Assessment, Centre for Health Services and Policy
Research, University of British Columbia. 1997 BCOHTA 97:2T pp.188 [988411]
http://www.chspr.ubc.ca//bcohta/pdf/bmd.pdf
Give me a feedback
Bests
------------------------------------------------------------------
Gruppo Italiano per la Medicina Basata sulle Evidenze
------------------------------------------------------------------
Antonino Cartabellotta, MD Phone:+39 091 407153
Head of GIMBE Fax: +39 091 407153
Passaggio L. da Vinci, 16 [log in to unmask]
90145 - Palermo (Italy) www.gimbe.org
------------------------------------------------------------------
G I M B E
------------------------------------------------------------------
__________________________________________________________________
EBM Niguarda Centre Phone: +39 02 64442864
Office for Quality Assurance Fax: +39 02 64442319
Niguarda Hospital
Piazza Ospedale Maggiore, 3 20162 - Milan (Italy)
__________________________________________________________________
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
|